ARTIVION, INC. reported first quarter ended March 31, 2026 results: revenue $116.3 million, net income $1.4 million, EPS $0.03 per fully diluted share. Guidance lowered.
“Total revenues for the first quarter of 2026 were $116.3 million, an increase of 18% on a GAAP basis and 12% on a non-GAAP constant currency basis, both compared to the first quarter of 2025. Net income for the first quarter of 2026 was $1.4 million, or $0.03 per fully diluted common share, compared to net loss of $(0.5) million, or $(0.01) per fully diluted common share for the first quarter of 2025.”
Material Agreements
ARTIVION, INC. entered into Securities Purchase Option Agreement with Endospan Ltd., the securityholders of Endospan listed on Schedule 1, and Shareholder Representative Services LLC valued at base purchase price of $175.0 million (effective 2019-09-11).
“on September 11, 2019, Artivion, Endospan, the securityholders of Endospan listed on Schedule 1 thereto (together with any additional securityholder that becomes a party by joinder, the “Securityholders”), and Shareholder Representative Services LLC, as the Securityholder representative, entered into a Securities Purchase Option Agreement”
Debt Financings
ARTIVION, INC. incurred term loan of $150.0 million with Ares Capital Corporation.
“a new $150.0 million secured delayed draw term loan facility (the “New Delayed Draw Term Loan Facility””
Debt Financings
ARTIVION, INC. amended credit facility with Ares Capital Corporation at base rate plus a margin of 3.75% or SOFR plus a margin of 4.75% maturing January 18, 2031.
“The Amendment provides for (i) an extension of the maturity date of the existing term loans (the “Existing Term Loan Facility”) and the existing revolving credit facility (the “Existing Revolving Credit Facility”) under the Credit Agreement by one year to January 18, 2031, (ii) a reduction in the interest rate margin applicable to the Existing Term Loan Facility and the Existing Revolving Credit Facility and (iii) a new $150.0 million secured delayed draw term loan facility (the “New Delayed Draw Term Loan Facility””
Governance Changes
ARTIVION, INC.: Amended and restated bylaws, updating advance notice provisions and making other changes in line with DGCL (effective 2024-05-15).
“On May 15, 2024, the Board of Directors (the “Board”) of Artivion, Inc. (the “Company”) approved amending and restating the Company’s amended and restated bylaws (the “Amended & Restated Bylaws”), effective immediately upon approval by the Board.”
Governance Changes
ARTIVION, INC.: Amended and restated certificate of incorporation to allow for officer exculpation under Delaware law (effective 2024-05-15).
“the Company’s stockholders approved the amendment and restatement of Artivion’s Certificate of Incorporation, as amended, to allow for officer exculpation as provided for under Delaware law (the “Amended and Restated Certificate of Incorporation”). The Company filed the Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware with an effective date of May 15, 2024.”
Shareholder Votes
ARTIVION, INC. shareholders approved Approval of the amendment and restatement of Artivion's Certificate of Incorporation to allow for officer exculpation at the 2024-05-14 meeting.
“Approval of the amendment and restatement of Artivion’s Certificate of Incorporation to allow for officer exculpation as provided for under Delaware law Votes For Votes Against Votes Abstain Broker Non-Votes 30,848,088 1,866,048 137,341 4,121,060”
Shareholder Votes
ARTIVION, INC. shareholders approved Ratification of the preliminary selection of Ernst & Young LLP as independent registered public accounting firm at the 2024-05-14 meeting.
“Ratification of the preliminary selection of Ernst & Young LLP as the independent registered public accounting firm for the Company for the year ending December 31, 2024 Votes For Votes Against Votes Abstain 36,785,277 64,594 122,666”
Shareholder Votes
ARTIVION, INC. shareholders approved Approval, by non-binding vote, of the compensation paid to Artivion's named executive officers at the 2024-05-14 meeting.
“Approval, by non-binding vote, of the compensation paid to Artivion’s named executive officers, including the Compensation Discussion and Analysis, compensation tables, and narrative discussion Votes For Votes Against Votes Abstain Broker Non-Votes 31,886,469 807,171 157,837 4,121,060”
Shareholder Votes
ARTIVION, INC. shareholders approved Election of Directors at the 2024-05-14 meeting.
“Name Votes For Votes Withheld Broker Non-Votes Thomas F. Ackerman 32,376,633 474,844 4,121,060 Daniel J. Bevevino 32,307,634 543,843 4,121,060 Marna P. Borgstrom 32,222,514 628,963 4,121,060 James W. Bullock 32,759,408 92,069 4,121,060 Jeffrey H. Burbank 27,413,096 5,438,381 4,121,060 Elizabeth A. Hoff 32,222,137 629,340 4,121,060 J. Patrick Mackin 32,526,399 325,078 4,121,060 Jon W. Salveson 32,254,634 596,843 4,121,060 Anthony B. Semedo 32,759,935 91,542 4,121,060”
Earnings Releases
ARTIVION, INC. reported full year 2024 results: revenue $382 to $396 million. Guidance initiated.
“The Company expects revenues for the full year 2024 to be in the range of $382 to $396 million”
Earnings Releases
ARTIVION, INC. reported full year ended December 31, 2023 results: revenue $354.0 million, net income ($30.7) million, or ($0.75) per fully diluted common share, EPS ($0.75) per fully diluted common share.
“fourth quarter of 2023 versus $79.4 million in the fourth quarter of 2022, an increase of 18% on a GAAP basis and 15% on a non-GAAP constant currency basis • Achieved revenue of $354.0 million for the full year of 2023 versus $313.8 million for the full year of 2022, an increase of 13% on a GAAP basis and 12% on a non-GAAP constant currency basis • Net loss was ($4.0)”
Earnings Releases
ARTIVION, INC. reported fourth quarter ended December 31, 2023 results: revenue $93.7 million, net income ($4.0) million, or ($0.10) per fully diluted common share, EPS ($0.10) per fully diluted common share.
“Phone: 770-419-3355 Artivion Reports Fourth Quarter and Full Year 2023 Financial Results Fourth Quarter and Recent Business Highlights: • Achieved revenue of $93.7 million in the fourth quarter of 2023 versus $79.4 million in the fourth quarter of 2022, an increase of 18% on a GAAP basis and 15% on a non-GAAP constant currency basis • Achieved”
Debt Financings
ARTIVION, INC. incurred credit facility of $190.0 million secured term loan facility, $100.0 million secured delayed draw term loan facility, and $60.0 million sec with Ares Capital Corporation at Term Loan Facilities: base rate plus 5.50% or SOFR plus 6.50%, stepping down to maturing January 18, 2030.
“On January 18, 2024 (the "Closing Date"), Artivion, Inc. ("Artivion") entered into a Credit and Guaranty Agreement (the "Credit Agreement"), among Artivion, as borrower, certain subsidiaries of Artivion, as guarantors, the lenders from time to time party thereto and Ares Capital Corporation, as administrative agent and collateral agent. The Credit Agreement provides for a $190.0 million secured term loan facility (the "Initial Term Loan Facility"), a $100.0 million secured delayed draw term loan facility (the "Delayed Draw Term Loan Facility" and, together with the Initial Term Loan Facility, the "Term Loan Facilities") and a $60.0 million "senior-priority" secured revolving credit facility (the "Revolving Credit Facility" and, together with the Term Loan Facilities, the "Credit Facilities").”
Material Agreements
ARTIVION, INC. entered into Credit and Guaranty Agreement with Ares Capital Corporation valued at $190.0 million secured term loan facility; $100.0 million secured delayed draw term loan facility; $ (effective 2024-01-18).
“On January 18, 2024 (the “Closing Date”), Artivion, Inc. (“Artivion”) entered into a Credit and Guaranty Agreement (the “Credit Agreement”), among Artivion, as borrower, certain subsidiaries of Artivion, as guarantors, the lenders from time to time party thereto and Ares Capital Corporation, as administrative agent and collateral agent.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.